JBS S.A. (JBSAY: OTCQX International Premier) | JBS S.A.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
JBS S.A. (JBSAY: OTCQX International Premier) | JBS S.A. Announces Termination of Tender Offers and Related Consent Solicitations for 10.50% Senior Notes Due 2016 and 10.25% Senior Notes Due 2016 JBS S.A. Announces Termination of Tender Offers and Related Consent Solicitations for 10.50% Senior Notes Due 2016 and 10.25% Senior Notes Due 2016

JBS S.A. Announces Termination of Tender Offers and Related Consent Solicitations for 10.50% Senior Notes Due 2016 and 10.25% Senior Notes Due 2016

PR Newswire

SAO PAULO , June 5, 2014 /PRNewswire/ -- On June 4, 2014 , JBS S.A. ("JBS") announced that it has terminated its previously announced cash tender offers (the "Tender Offers") and related solicitations of consents (the "Consent Solicitations") for (i) any and all of the outstanding US$300,000,000 aggregate principal amount of 10.50% Senior Notes due 2016 of JBS and JBS Finance Ltd. (the "2016 Notes") and (ii) any and all of its outstanding US$350,000,000 aggregate principal amount of 10.25% Senior Notes due 2016 (together with the 2016 Notes, the "Notes").

Each Tender Offer and Consent Solicitation was subject to the conditions set forth in the Offer to Purchase and Consent Solicitation Statement, dated May 28, 2014 , and the related Letter of Transmittal and Consent, which contain detailed information concerning the terms of the tender offers and the consent solicitations (together, the "Offer Documents").  These conditions included, among others, the consummation of a new offering of senior unsecured notes by JBS USA , LLC and JBS USA Finance, Inc., each a subsidiary of JBS (the "New Offering"). 

As a result of the termination, none of the Notes that have been tendered in the Tender Offer will be accepted for purchase and no consideration will be paid or become payable to holders of Notes who have tendered their Notes in the Tender Offer.  All Notes previously tendered and not withdrawn will be promptly returned or credited back to their respective holders.  All consents previously delivered and not revoked will be of no effect, and the indentures governing the Notes will remain in their present form, unamended.

The Tender Offers and Consent Solicitations are being terminated because the New Offering has been postponed.   JBS reserves the right to initiate a new tender offer and consent solicitation for the Notes at a later date, but it is under no obligation to do so.

This press release confirms formal termination of the Tender Offers and Consent Solicitations

Holders of Notes with questions regarding the termination of the Tender Offers and Consent Solicitations may direct such questions to D.F. King at (800) 758-5378 (toll free), (212) 269-5550 (collect) or jbs@dfking.com .

Neither the Offer Documents nor any related documents have been filed with the U.S. Securities and Exchange Commission, nor have any such documents been filed with or reviewed by any federal or state securities commission or regulatory authority of any country.  No authority has passed upon the accuracy or adequacy of the Offer Documents or any related documents, and it is unlawful and may be a criminal offense to make any representation to the contrary.

Under no circumstances shall this press release constitute an offer to buy or the solicitation of an offer to sell the Notes or any other securities of JBS or its affiliates.  This press release is not a solicitation of consents to the proposed amendments to the indentures relating to the Notes.

About JBS

JBS is the world's largest protein company and processes, prepares, packages and delivers fresh, further processed and value-added beef, pork, lamb and poultry products in approximately 170 countries on six continents.

Important Notice Regarding Forward-Looking Statements

This press release contains certain forward-looking statements.  Statements that are not historical facts, including statements about our perspectives and expectations, are forward looking statements.  The words "expect," "believe," "estimate," "intend," "plan" and similar expressions, when related to JBS and its subsidiaries, indicate forward-looking statements.  These statements reflect the current view of management and are subject to various risks and uncertainties.  These statements are based on various assumptions and factors, including general economic, market, industry and operational factors.  Any changes to these assumptions or factors may lead to practical results different from current expectations.  Excessive reliance should not be placed on those statements.  Forward-looking statements relate only to the date they were made and JBS undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date they were made.

 

SOURCE JBS S.A.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 10

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 20

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 24

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 22

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 20

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 11

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 14

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding F5 Inc.'s Stock Performance and Valuation

Updated Category News Views 180

Analyzing F5 Inc.'s Stock Metrics In today's market, F5 Inc. (NASDAQ: FFIV) is trading at $315.70 after experiencing a slight decrease of 0.48%. Interestingly, over the past month, the company has seen its stock rise by 5.50%, and in the last year, it has impressively increased by 58.08%. This growth prompts shareholders to contemplate whether the stock's current...

Continue Reading
Jeffs’ Brands Enters Strategic Agreement for Security Tech Expansion

Updated Category News Views 127

Exploring New Horizons: Jeffs’ Brands' Non-Binding MOU The 3D, AI-Powered Technology Screens 25,000 People Per Hour—Without Stopping Them In an exciting development for Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (NASDAQ: JFBR, JFBRW), a leading data-driven e-commerce firm leveraging the Amazon Marketplace, the company has announced its wholly owned...

Continue Reading
Essential Tips for Managing Chronic Back Pain and Health

Updated Category News Views 94

Understanding Pain Awareness Month September signals National Pain Awareness Month, a significant time to shed light on the challenges and treatment options for managing pain. Chronic pain impacts millions worldwide, deeply affecting day-to-day life. In particular, lower back pain is alarming, affecting over 619 million people globally according to recent statistics....

Continue Reading
Nerivio® REN Wearable Receives Approval in China for Migraine Relief

Updated Category News Views 336

Pier 88 Health and Theranica Revolutionize Migraine Treatment Pier 88 Health, a pioneer in digital health, and Theranica have announced a significant advancement in migraine treatment. Their groundbreaking product, the Nerivio® REN wearable, is now approved by China's National Medical Products Administration (NMPA), marking a pivotal moment for those suffering from this...

Continue Reading
Join the Excitement of CARNIVALE 2026 at Grace Cathedral

Updated Category News Views 198

Experience the Vibrant CARNIVALE 2026 Celebration Grace Cathedral, the cherished Episcopal landmark, is proud to announce the return of its spectacular Mardi Gras gala, CARNIVALE 2026. This exciting event is scheduled for February 13, 2026, promising to be a grand festive evening filled with joy and celebration. The Theme: Noite de Carnaval This year's theme, Noite de...

Continue Reading